A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, EFFICACY AND SAFETY STUDY OF HBS-301 IN PARTICIPANTS WITH IDIOPATHIC HYPERSOMNIA (IH) FOLLOWED BY AN OPEN-LABEL EXTENSION

Registry ID

HBS-301-CL-302

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

HARMONY BIOSCIENCES MANAGEMENT, INC.

Last update

2026-06-29

Conditions

• IDIOPATHIC HYPERSOMNIA

Related clinical trials

• A LONG-TERM EXTENSION STUDY OF THE SAFETY AND EFFICACY OF CLEMINOREXTON IN PARTICIPANTS WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA WHO COMPLETED A SPONSORED CLEMINOREXTON CLINICAL TRIAL
• A PHASE 2A, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ORX750 IN SUBJECTS WITH NARCOLEPSY AND IDIOPATHIC HYPERSOMNIA ¿ (CRYSTAL-1)

View on source registry